Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling
- 201 Downloads
The primary obstacle to treat cervical cancer is its high prevalence of metastasis, which severely affects patients’ quality of life and survival time. Nucleolar and spindle associated protein 1 (NUSAP1) has been implicated in the development, progression, and metastasis in several types of cancer. However, its oncogenic role in cervical cancer remains unclear.
Western blot assay and immunohistochemistry were used to determine the expression of NUSAP1 in 21 clinical fresh Cervical cancer tissues and 233 clinicopathologically characterized cervical cancer specimens. The biological roles of NUSAP1 in the metastasis of cervical cancer were investigated both in vitro by EMT, Side population analysis and Transwell assays and so on, and in vivo using a mouse 4w model of hematogenous metastasis and lymph node metastasis. Bioinformatics analysis, luciferase reporter analysis, immunoprecipitation and immunoblotting of nuclear and cytoplasmic cellular fractions were applied to discern and examine the relationshipbetween NUSAP1 and its potential targets.
The results demonstrated that NUSAP1 was upregulated in cervical cancer cells and tissues, correlated positively with metastasis and poor clinical outcome of patients. High expression of NUSAP1 promoted metastasis by enhancing cancer stem cell (CSC) traits and epithelial-mesenchyme transition (EMT) progression, while silencing of NUSAP1 reduced CSC traits and EMT progression. Mechanistically, upregulation of NUSAP1 induced SUMOylation of TCF4 via interacting with SUMO E3 ligase Ran-binding protein 2 (RanBP2) and hyperactivated Wnt/β-catenin signaling in cervical cancer cells. Additionally, NUSAP1-induced cervical cancer cells metastasis and the cancer stem cell phenotype were abrogated with the Wnt/β-catenin signaling inhibitor XAV-939 treatment. Importantly, co-therapy of conventional treatment and XAV-939 will provide a novel and effective treatment for NUSAP1-ovexpressed cervical cancer patients.
Our results demonstrate thatNUSAP1 upregulation contributes to metastasis of cervical cancer by promoting CSC properties and EMT via Wnt/β-catenin signaling and XAV-939 might serve as a potential tailored therapeutic option for patients with NUSAP1-ovexpressed cervical cancer.
KeywordsNUSAP1 Cervical cancer Metastasis Epithelial-mesenchyme transition Cancer stem cell Wnt/ β-catenin signaling
American type culture collection
Basic fibroblast growth factor
B lymphoma Mo-MLV insertion region 1 homolog
Cancer stem cell
Dulbecco’s modified eagle medium
Epidermal growth factor
Eagle’s Minimum Essential Medium
Fetal bovine serum
The Gene Expression Omnibus
Gene set enrichment analysis
Lipoprovein receptor-related protein-5 or − 6
Matrix metalloproteinase 7
Matrix metalloproteinase 9
homeobox transcription factor Nanog
Nuclear pore complex
Nucleolar and spindle associated protein 1
Octamer-binding protein 4
Quantitative real-time reverse transcription polymerase chain reaction
Ran binding protein-2
Roswell Park Memorial Institute-1640
The staining intensity
The small ubiquitin-related modifier
T-cell factor/lymphoid enhancer factor
The Cancer Genome Altlas
Cervical cancer is the fourth leading cause of tumor-related death in women worldwide, with an incidence of 530,000 new cases annually . With recent advances in surgery, chemotherapy, and radiotherapy, the 5-year survival rate of patients with cervical carcinoma undergoing standardized treatment can be up to 80%. However, once local metastasis (especially lymph node metastasis) or distant metastasis occurs, the 5-year survival rate drops to barely 50% . The development of metastasis is a serious limitation of long-lasting, effective treatments for cervical cancer patients [3, 4]. Thus, there is an urgent need to explore the underlying molecular mechanism of cervical carcinoma metastasis and to identify new therapeutic targets.
Nucleolar and spindle associated protein 1 (NUSAP1) binds microtubules, and functions in mitotic progression, spindle formation, and stability [5, 6]. Previous studies showed that NUSAP1 is upregulated in several cancers, including prostate cancer, colorectal cancer, and astrocytoma [7, 8, 9, 10]. High expression of NUSAP1 was markedly associated with unfavorable prognosis of breast cancer and melanoma [11, 12]. Moreover, overexpression of NUSAP1 enhanced the progression and invasion of astrocytoma and prostate cancer cells [9, 10]. These observations suggested that upregulation of NUSAP1 correlates with cancer progression. However, the function of NUSAP1 in cervical cancer remains unknown.
The Wnt/β-catenin signaling pathway has a pivotal role in regulating metastatic ability, and is constitutively activated in numerous cancers, including cervical cancer [13, 14, 15, 16, 17]. Upon activation, Wnt ligands bind to its frizzled receptors and lipoprovein receptor-related protein-5 or − 6 (LRP5/6) co-receptors, which induce translocation and accumulation of β-catenin in the nucleus. Next, β-catenin interacts with the T-cell factor/lymphoid enhancer factor (TCF/LEF) transcription factor to form a complexin cell nuclei, which activates the transcription of target genes. Moreover, the Wnt/β-catenin pathway has a prominent role in the progression processes of various cancers, including epithelial mesenchymal transition (EMT) and cancer stem cell (CSC) properties, which contribute to metastasis in multiple types of cancer [18, 19, 20, 21, 22, 23]. However, the association between metastasis and the Wnt/β-catenin pathway in cervical carcinoma remains unclear. Therefore, the present study analyzed the role of NUSAP1 in cervical cancer, and we assessed the association with the Wnt/β-catenin pathway in the progression and metastasis of cervical cancer.
SUMOylation is a type of post –translational modification that a target protein is covalently conjugated with the small ubiquitin-like modifier (SUMO) to specific lysine residues through formation of isopeptide bonds [24, 25]. SUMOylation is a multi-step reaction that is sequentially catalyzed by a SUMO-activating E1 enzyme, the single conjugating E2 enzyme Ubc9, and an E3 ligase, such as members of the PIAS/Siz protein family or RanBP2, which act in concert with Ubc9 as enhancers in the modification process. SUMO modification generally alters the properties of the modified target by influencing –either positively or negatively –its interactions with other cellular factors . Additionally, SUMOylation has attracted increasing attention as widely involved in carcinogenesis, cancer cell proliferation, metastasis and apoptosis, implicating SUMOylation as an important regulator of the progression of cancer . However, the roles of SUMOylation in the aspects of cervical cancer cells development and progression, especially in metastasis and invasion, remain unclear.
The results showed that NUSAP1 was upregulated in cervical cancer cell lines, and NUSAP1 could serve as an independent prognostic indicator for unfavorable clinical outcomes. Moreover, NUSAP1 induced SUMOylation of TCF4 via interacting with SUMO E3 ligase Ran-binding protein 2 (RanBP2) and potently activated the Wnt/β-catenin signaling pathway, thus contributing to the metastatic and CSC-likeproperties of cervical cancer cells. Therefore, our study revealed a potential mechanism for Wnt/β-catenin pathway activation, and suggested NUSAP1 as a novel therapeutic target in patients with cervical carcinoma.
Human cervical cancer cells HeLa, CaSki, C33A, SiHa, MS751, and ME-180,and the human cervical immortalized cell line ECT1/E6E7, were purchase from the American Type Culture Collection (ATCC, Manassas, VA, USA). HCC94 and HeLa229 cell lines were obtained from Shanghai Chinese Academy of Sciences cell bank (China). HeLa, CaSki, SiHa and MS751 cells were grown in Eagle’s Minimum Essential Medium (ATCC-30-2003) supplemented with 10% fetal bovine serum (FBS, Life Technologies). HCC94 cells were grown in RPMI-1640 medium (Life Technologies, Carlsbad, CA, US) supplemented with penicillin G (100 U/ml), streptomycin (100 mg/ml) and 10% fetal bovine serum (FBS, Life Technologies). HeLa229 and ME-180 cells were grown in Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 10% FBS.ECT1/E6E7 cells were cultured in Keratinocyte-Serum Free medium (GIBCO-BRL 17005–042) with 0.1 ng/ml human recombinant EGF, 0.05 mg/ml bovine pituitary extract, and additional calcium chloride 44.1 mg/L (final concentration 0.4 mM). All cell lines were grown under a humidified atmosphere of 5% CO2 at 37 °C.
Patients and tissue specimens
Our study was performed using 233 paraffin-embedded cervical carcinoma samples, which were took from patients diagnosed at the Sun Yat-Sen University Cancer Center. These specimens were obtained from 140 patients with stage I, 90 patients with stage II, and two patients with stage III cervical cancer who received surgery and postoperative chemotherapy or radiation, according to pathological high-risk factors, from 2005 to 2010. None these patients received any anti-cancer therapy before surgery. Information on the clinical characteristics of the patients with cervical cancer is summarized in the Additional file 1: Table S1. For quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) and western blotting analysis, fresh cervical cancer and matched noncancerous cervical tissues samples were obtained from sevenpatients, and fresh cervical cancer samples were resected from six patients without metastasis and from eight patients with metastasis. Surgeries were performed at the Sun Yat-sen University Cancer Center between January 2017 and May 2017. Ethics approval and written informed consent for the use of the specimens were provided by the Institutional Research Ethics Committee.
Gene set enrichment analysis (GSEA)
Gene Set Enrichment Analysis (GSEA) is a computational method that determines whether an a prior defined set of genes shows statistically significant, concordant differences between two biological states (e.g. phenotypes). The results presented in the current manuscript use the two phenotypes divided by the median of NUSAP1 mRNA expression of Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) TCGA data. GSEA was performed using GSEA 2.0.9 (http://www.broadinstitute.org/gsea/) according to its guideline [28, 29]. The gene sets (the curated gene sets C2) were downloaded from GSEA 2.0.9 (http://www.broadinstitute.org/gsea/).
Cells were seeded in 96-well plates at initial density of (0.2 × 104/well). At each time point, cells were stained with 100 μL sterile 3-(4, 5-dimethyl-2-thiazolyl)-2,5-diphenyl- 2H-tetrazolium bromide (MTT) dye (0.5 mg/mL, Sigma) for 4 h at 37 °C, followed by removal of the culture medium and addition of 150 μL of dimethyl sulphoxide (Sigma). The absorbance was measured at 490 nm using a microplate reader (Bio-Rad). The experiment was repeated three times.
RNA extraction, reverse transcription, and quantitative real-time PCR
RNA extraction, reverse transcription, and real-time PCR were performed as described previously . The primers were designed using primer Express Software v.2.0 and comprised: NUSAP1 forward: 5′-CTGACCAAGACTCCAGCCAGAA-3′ and reverse: 5′-GAGTCTGCGTTGCCTCAGTTGT-3′; SRY-Box 2 (SOX2) forward: 5′-GCTACAGCATGATGCAGGACCA-3′ and reverse: 5′-TCTGCGAGCTGGTCATGGAGTT-3′; octamer-binding protein 4 (OCT4) forward: 5′-CCTGAAGCAGAAGAGGATCACC-3′ and reverse: 5′-AAAGCGGCAGATGGTCGTTTGG-3′; homeobox transcription factor Nanog (NANOG) forward: 5′-CTCCAACATCCTGAACCTCAGC-3′ and reverse: 5′-CGTCACACCATTGCTATTCTTCG-3′; B lymphoma Mo-MLV insertion region 1 homolog (BMI1) forward: 5′-GGTACTTCATTGATGCCACAACC-3′ and reverse: 5′-CTGGTCTTGTGAACTTGGACATC-3′; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forward: 5′-GTCTCCTCTGACTTCAACAGCG-3′ and reverse: 5′-ACCACCCTGTTGCTGTAGCCAA-3′; MYC forward: 5′-CGTCCTCGGATTCTCTGCTC-3′ and reverse: 5′-GCTGGTGCATTTTCGGTTGT-3′; matrix metalloproteinase 7 (MMP7) forward: 5′-TCGGAGGAGATGCTCACTTCGA-3′ and reverse: 5′-GGATCAGAGGAATGTCCCATACC-3′; matrix metalloproteinase 9 (MMP9) forward: 5′-GCCACTACTGTGCCTTTGAGTC-3′ and reverse: 5′-CCCTCAGAGAATCGCCAGTACT-3′; CD44 forward: 5′-CCAGAAGGAACAGTGGTTTGGC-3′ and reverse: 5′-ACTGTCCTCTGGGCTTGGTGTT-3′.All experiments were conducted three times. Additionally, GAPDH was chose as the internal control to normalize the expression levels of all the genes in the samples, and the fold changes were calculated using the relative quantification 2- [(cycle threshold (Ct) of gene)-(Ct of GAPDH)].
Western blotting analysis
Western blotting assays  were conducted using anti-NUSAP1 rabbit polyclonal antibodies (SAB1407458, Sigma-Aldrich, St Louis, MO, USA), antibodies against p84(ab102684, Abcam), GAPDH (D16H11, Cell Signaling), α-tubulin (#3873, Cell Signaling), E-cadherin(#14472, Cell Signaling), vimentin(#5741, Cell Signaling), MYC (#2276, Cell Signaling), MMP7(#71031, Cell Signaling), MMP9(D603H, Cell Signaling), CD44(#37259, Cell Signaling), SUMO-1 (#4930, Cell Signaling),TCF4 (#2569, Cell Signaling), RanBP2 (ab2938, Abcam, Cambridge, MA) and β-catenin(#8480,1:1000, Cell Signaling). GAPDH, α-tubulin, or P84 were used as the endogenous controls.
Lysates were prepared from Siha cells using lysis buffer (150 mM NaCl, 10 mM HEPES, pH 7.4, 1% NP-40). Lysates were then incubated with HA affinity agarose (Sigma-Aldrich), or NUSAP1 or RanBP2 antibody with protein G agarose, overnight at 4 °C. Beads containing affinity-bound proteins were washed 6 times by immunoprecipitation wash buffer (150 mM NaCl, 10 mM HEPES, pH 7.4, 0.1% NP-40), followed by elutions 1 M glycine (pH 3.0). The eluates were then mixed with sample buffer and denatured, and used for the western blot analysis.
Immunohistochemical staining was carried on the 233 paraffin-embedded cervical carcinoma tissues using anti-NUSAP1 antibodies (HPA024904,1:600, Sigma) and antibodies against β-catenin(#8480,1:1000, Cell Signaling). The degree of immunostaining was reviewed and assessed in a blinded manner by two independent pathologists. We defined the score of cell proportions as follows: 0, no positive cells; 1, < 10% positive cells; 2, 10–35% positive cells; 3, 35–75% positive cells; 4, > 75% positive cells. Staining intensity was graded using the following standard: 0, no staining; 1, weak staining (light yellow); 2, moderate staining (yellow brown); 3, strong staining (brown). The staining intensity (SI) was evaluated multiplying the staining intensity score by the proportion of positive tumor cells. During the assessment, we used the SI to evaluate the NUSAP1 and nuclear β-catenin protein expression levels. The possible scores were 0, 1, 2, 3, 4, 6, 8, 9, and 12. Specimens with a score ≥ 6 were defined as having high NUSAP1 or nuclear β-cateninexpression, and samples with a score < 6 were defined as having low NUSAP1 or nuclear β-catenin expression.
Plasmids, retroviral infection, and transfection
The NUSAP1 cDNA was amplified using PCR and subcloned into vector pMSCV-puro-NUSAP1. We cloned two short hairpin RNA (shRNA) oligonucleotides to produce pSuper-puro-NUSAP1-shRNA to knockdown endogenous NUSAP1(RNA#1: 5′-GCACCAAGAAGCTGAGAATGC-3′,and RNA#2:5′- GGAAATGGAGTCCATTGATCA-3′). The Lipofectamine 3000 reagent (Invitrogen) was used to transfect the plasmids into cells, following the manufacturer’s instructions. Stable cell lines expressing NUSAP1 or NUSAP1 shRNA were selected for 10 days by treatment with 0.5 μg/ml of puromycin for 48 h after infection. The sequence of RanBP2 siRNA was GAAUAACUAUCACAGAAUG .
Wound healing assay
Six-well plates were seeded with cells transfected with vector, NUSAP1, shRNA-vector, or NUSAP1 shRNA and incubated under suitable conditions until 90% confluence was reached. Wounds were induced by scratching the confluent cells using a pipette tip after 48 h of serum starvation. The cells were washed with phosphate-buffered saline (PBS) three times and then incubated in RPMI-1640 medium. At the indicated times (including time 0), the wounds were photographed under an inverted Olympus IX50 microscopeand measured. Each experiment was performed at least three times.
The invasion assay was conducted using aTranswell chamber with an 8-mm membrane filter insert (Corning) with Matrigel (BD,Biosciences). Briefly, the indicated cells were cultured in serum-free medium. The cells were placed into the upper chamber, and the lower chamber was supplied with 1 ml of medium containing 10% FBS. After 48 h of incubation at 37 °C, the cells in the upper chamber were gently removed using a cotton swab. The migratedcells on the lower membrane surface were fixed in 1% paraformaldehyde, stained with hematoxylin, and counted (ten random fields per well; 100× magnification). The count number was represented as the mean number of cells per field of view. All the experiments were conducted in triplicate andthe data are presented as the mean ± standard deviation (SD).
Sphere formation assays
The indicated cells were implanted into six-well ultra-low attachment plates. Cells were incubated in the Dulbecco’s modified Eagle’s medium (DMEM)/F12 serum-free medium (Invitrogen) with 20 ng/ml epidermal growth factor (EGF), 2% B27 (Invitrogen), 5 μg/ml insulin (Sigma-Aldrich), 0.4% bovine serum albumin (Sigma-Aldrich), and 20 ng/ml basic fibroblast growth factor (bFGF; PeproTech). After 10 days of incubation, the number of spheres was calculated and their volume was assessed on a BX-X700 fluorescence microscope (Keyence, Osaka, Japan). The experiment was carried out three times.
Side population analysis
To analyze the side population cells proportion, the cell suspensions were labeled with Hoechst 33,342 (Sigma-Aldrich) dye for side population analysis as per standard protocol [31, 32]. Briefly, cells were resuspended at EMEM medium (ATCC-30-2003) containing 2%FBS (Gibco, USA) at a density of 106/mL. Hoechst 33,342 dye was added at a final concentration of 5 Ig/ml in the presence or absence of verapamil (Sigma-Aldrich) and the cells were incubated at 37 °C for 90 min with intermittent shaking. At the end of the incubation, the cells were washed with EMEM medium adding 2%FBS and centrifuged down at 4 °C, and resuspended in ice-cold EMEM medium. Propidium iodide (Sigma, USA) at a final concentration of 2 Ig/mL was added to cells to gate viable cells. The cells were filtered through a 40-lm cell strainer to obtain single cell suspension before sorting. Analysis and sorting was done on a FACS AriaI (Becton Dickinson). The Hoechst 33,342 dye was excited at 355 nm and its dual-wavelength emission at blue and red region was plotted to get the SP scatter.
The indicated cells were placed on 24-well plate and then incubated at 37 °C in 5% CO2 overnight. The cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100 before being blocked with 1% BSA in PBS buffer for 1 h the next day. Cells were incubated with primary antibodies against E-cadherin (1:400) (24E10, Cell Signaling) and vimentin (1:50) (D21H3,Cell Signaling),whichwere conjugated with Alexa Fluor 488 and Alexa Fluor 555, respectively, at room temperature for 1 h in the dark. Cell nuclei were stained with 4,6 diamidino-2-phenylindole (DAPI, Sigma) for 3 min. The cells were then visualized and photographed under a confocal laser-scanning microscope (Olympus FV1000, Japan).
Cells were implanted in 48-well plates and incubated for 24 h. One nanogram of the pRL-TK Renilla plasmid (Promega) containing the TOP-Flash or FOP-Flash luciferase reporter were transfected into the cells using the Lipofectamine 2000 Reagent (Invitrogen). A Dual-Luciferase Reporter Assay kit (Promega) was used to detect the luciferase activity of the indicated cells according to the manufacturer’s instructions.
BALB/c-nu mice (female, 3–5 weeks old; weighing 11–13 g) were purchased from Hunan SJA Laboratory Animal Co. Ltd. (Changsha, China). All experimental procedures were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University. As for thelung metastasis colonization mousemodels, the BALB/c-nu mice were randomly separated into four groups (n = 6/group) and injected with 5 × 105cells (SiHa-vector/SiHa-NUSAP1;SiHa-shRNA-Vector/SiHa-NUSAP1-shRNA#1) through their tail veins. The Xenogen IVIS spectrum imagining system (Caliper) was used to assess the bioluminescence of tumor colonization and growth in the lung and popliteal lymph node tissues. At the end of the experiment (45 days), the mice were euthanized and their lungs were excised, fixed in formalin, and paraffin-embedded for the hematoxylin and eosin staining. The numbers of lung surface metastatic nodules were calculated under a dissecting microscope and expressed as the mean ± standard error of the mean (SEM). As for the lymph node metastatic mouse model, the BALB/c-nu mice were randomly divided into four groups (n = 6/group). The NUSAP1, NUSAP1-RNA#1 or vector-transduced SiHa cells (1.5 × 105), which stably express firefly luciferase, were inoculated into the foot-pads of the mice. The mice were sacrificed on day 45, and the primary tumours and popliteal lymph nodes were excisedand paraffin embedded. Serial 4.0 mm sections were taken and analysed by IHC with anti-luciferase antibodies (Abcam). All animal studies were conducted withthe approval of the Medical Experimental Animal CareCommission of Sun Yat-sen University Cancer Center.
Bioinformatics and data analysis
NUSAP1 mRNA expression in normal cervix and cervical cancer tissues were examined based on The Cancer Genome Atlas (TCGA; https://gdc.cancer.gov/) and the Gene Expression Omnibus (GEO) dataset (GSE7803 and GSE9750) (see URL https://www.ncbi.nlm.nih.gov/geo). Wedownloaded the SeriesMatrix File. Gene expression was presented as the mean value of multiple probes for eachgene after log2 transformation. Comparisons (normal cervix tissues versus cervical cancertissues) were analyzed by Mann-Whitney U test. P < 0.05 was considered statistically significant.
The statistical analyses were conducted using the SPSS 16.0 statistical software package (IBM, Armonk, NY, USA). Kaplan–Meier analysis was applied to establish survival curves and the log-rank test was used to evaluate the statistically significant differences. Student’s t-test (two-tailed) was performed to compare the continuous data. In addition, other statistical methods for data analysis included Fisher’s exact test, chi-squared (χ2) test, Mann-Whitney U test, Spearman correlation analysis, and multivariate cox regression analysis. P value of < 0.05 was regarded as statistically significant in all cases.
Expression of NUSAP1 in cervical cancer
Clinical significance of NUSAP1 in cervical cancer
Influence of expression levels of NUSAP1 on migration and invasion capacity of cervical cancer cells both in vitro and in vivo
NUSAP1 promotes epithelial-mesenchymal transition
NUSAP1 promotes the CSCs properties in cervical cancer
NUSAP1 activates Wnt/β-catenin pathway in cervical cancer cells
The Wnt/β-catenin signaling pathway is required for NUSAP1-mediated cervical cancer cells metastasis and clinical relevance of NUSAP1 and β-catenin activation in human cervical carcinoma
In the present study, we showed that NUSAP1 was overexpressed in cervical cancer and correlated with unfavorable clinical outcome, especially via its critical role in promoting metastasis. NUSAP1 was associated with enhanced metastatic potential, both in vitro and in vivo. Moreover, increased levels of NUSAP1 were associated with CSCs properties of cervical cancer. In addition, our results indicated that NUSAP1 promotes metastasis of cervical cancer cells by inducing the sumoylation of TCF4 via interact with SUMO-E3 ligase Ran-binding protein2 (RanBP2) and then enhance the Wnt/β-catenin signaling activity. Taken together, the results presented a novel mechanism by which NUSAP1 persistently activates Wnt/β-catenin signaling, demonstrating the significant role of NUSAP1 in the metastasis of cervical cancer cells.
Recently, the important roles of NUSAP1 in tumorigenesis have been revealed in several types of tumor. NUSAP1 expression was correlated with BRCA1, BRCA2, and BARD1 expression, and upregulation of NUSAP1 predicted poor prognosis in triple-negative breast cancer [11, 34]. Okamoto  demonstrated that inhibition of NUSAP1 suppressed tumor proliferation and enhanced the anti-tumor effect of paclitaxel by activating apoptotic pathways in oral squamous cell carcinoma. NUSAP1 has been reported as a potential prognostic marker for patients with glioma, and knockdown of NUSAP1 suppressed the proliferation of glioma cells by inducing G2/M phase cell cycle arrest and apoptosis . In colorectal cancer, NUSAP1 is an independent prognostic biomarker and its depletion induced cell apoptosis, and inhibited cell migration, cell invasion, cell proliferation, and EMT by inhibiting the expression of DNA methyltransferase 1 (DNMT1) . Moreover, NUSAP1 expression has a significant role in the prediction of clinical outcome in hepatocellular carcinoma, in which NUSAP1regulates cellular proliferation, migration, and growth . These studies indicated that NUSAP1 might have an important role in enhancing the malignant properties of human cancers, which leads to poor patient prognosis. In the present study, we revealed the oncogenic role and prognostic significance of NUSAP1 in cervical cancer, which agreed with the findings detailed above. Furthermore, we showed that overexpression of NUSAP1was markedly associated with lymph node metastasis and promoted cervical cancer cells metastasis by activating the Wnt/β-catenin pathway. Thus, our study provides evidence for the clinical and biological significance of NUSAP1 in cervical cancer.
Despite recent advances in cervical cancer diagnosis and treatment, mortality from this tumor mainly results from its metastasis to lymph nodes and distant organs [33, 34, 38]. Song et al. reported that more than 90% of patients with the earliest stage of cervical cancer survive for over 5 years after diagnosis, whereas those diagnosed at later stages (i.e., with metastasis) have poor clinical outcome . These reports indicated that metastasis is the major obstacle to improving treatment and prolonging the survival of patients with cervical cancer. Moreover, several reports demonstrated that CSCs and EMT are closely correlated with metastasis [39, 40, 41]. Prompted by these reports, we further examined CSCs and EMT in cervical cancer cells to detect the role of NUSAP1 in metastasis.
CSCs have an important function in the process of metastasis in various cancers, including cervical cancer [39, 42, 43, 44]. Moreover, a growing body of evidence shows that the Wnt/β-catenin signaling correlates significantly with the CSCs self-renewal, and enhances the invasion, metastasis, and tumorigenicity . However, the mechanisms underlying the maintenance of the CSC population and its clinical relevance in cervical carcinoma remain elusive. In the present study, we reported that NUSAP1 significantly enhanced tumor sphere formation and the expression levels of several stem cell-related genes in vitro, and promoted metastasis in vivo. Consistently, NUSAP1 increased the proportion of side population phenotypes cells, which is regarded as a characteristic feature of CSCs , indicating that NUSAP1 may promote the stemness of cervical cancer cells. Therefore, our findings revealed a new mechanism linking the maintenance of CSCs with metastasis in cervical carcinoma. Importantly, our study might also provide a potential target for reduce the population of CSCs in cervical cancer.
Numerous lines of evidence have shown that EMT has pivotal roles in metastasis in several types of cancer [15, 18, 47, 48]. In the present study, we showed that high expression of NUSAP1 induces an EMT-like phenotypic transition and metastasis in cervical cancer cells. In addition, the Wnt/β-catenin pathway has been implicated in EMT and induces metastasis in several types of cancers [19, 49, 50]. Consistent with these reports, our study indicated that upregulation of NUSAP1 activated Wnt/β-catenin signaling in cervical cancer cells. Moreover, inhibiting Wnt/β-catenin signaling using the tankyrase inhibitor XAV-939 and β-catenin-siRNA in NUSAP1-overexpressing cells confirmed that Wnt/β-catenin pathway was required for NUSAP1-mediated EMT. Although the precise mechanisms of NUSAP1-induced EMT requires further investigation, we believe that high expression of NUSAP1 promotes EMT and induces metastasis in cervical cancer cells at least partly depending on activated Wnt/β-catenin signaling. Therefore, our data suggested that NUSAP1 might represent as a new regulator of EMT and may also represent a potential therapeutic target in cervical cancer.
Previous reports showed that Wnt/β-catenin signaling promotes invasion, metastasis, and tumorigenesis [51, 52, 53, 54]. Nevertheless, the precise mechanism that maintains stemness and promotes EMT via the Wnt/β-catenin pathway in cervical cancer remains unclear. In this study, we identified that NUSAP1 interacted with an nuclear pore complex (NPC) protein, RanBP2 and TCF4. We also found that TCF4 was SUMOylation by RanBP2. Modification of proteins by SUMO is involved in a large variety of molecular processes such as protein-protein interaction, subcellular localization and transcriptional activity . Our results also reveal that NUSAP1 increased the nuclear import of the TCF4 and β-catenin and their transcriptional activity via interacting with RanBP2 protein, and then enhanced CSCs properties and EMT processes in cervical cancer. SUMO1 modification appears to be an“ON/OFF”switch that regulates the nuclear import of β-catenin . The final output of Wnt signaling is the formation of TCF/LEF and β-catenin nuclear complexes. NUSAP1 overexpression induced SUMOylation of TCF4 via binding NPC protein, RanBP2, is involved in the process of cervical cancer metastasis and progression. Wnt/β-catenin signaling has been indicated in manymalignancies, targeting this pathway could represent an attractive anticancer therapy. In the present study, a small molecule, XAV-939, a WNT signaling inhibitor, was used to inhibit catenin transcription . Notably, adding XAV-939 remarkably repressed cancer stem cell properties and metastasis processes in cervical cancer cells. Metastasis is the main obstacle affecting the survival of patients with advanced cervical cancer, thus, identifying biomarkers and genotypes for predicting metastasis in the progression of cervical cancer and preventing the development of metastasis will be beneficial for a large group of cervical cancer patients. The results of these studies will not only contribute to our understanding of NUSAP1 to cervical cancer metastasis but will also lead to the characterization of specific tumor patients’ groups with NUSAP1 overexpression who may benefit from co-therapy of traditional treatment and XAV-939.
In summary, NUSAP1 contributes to metastasis of cervical cancer by inducing the sumoylation of TCF4 via interact with SUMO-E3 ligase Ran-binding protein2 (RanBP2) and then enhance the Wnt/β-catenin signaling activity. Moreover, NUSAP1 could be used to predict postoperative metastasis and recurrence in patients with cervical cancer, and a Wnt/β-catenin pathway inhibitorXAV-939 may serve as a potential tailored treatment for NUSAP1-ovexpressed cervical cancer patients. Moreover, future studies are needed to determine the in-depth mechanisms underlying metastasis induced by upregulation of NUSAP1.
This study was supported by grants from the National Natural Science Foundation of China (81672579 and 81872124).
Availability of data and materials
The datasets generated and/or analysed during the current study are available in the National Center for Biotechnology Information Gene Expression Omnibus website (https://www.ncbi.nlm.nih.gov/geo/). Gene Set Enrichment Analysis (GSEA) was performed using GSEA 2.2.1 (http://www.broadinstitute.org/gsea) and gene set was performed by Molecular Signatures Database v5.2 (http://software.broadinstitute.org/gsea/msigdb).
HL and YZ developed ideas and drafted the manuscript. WZ, MY conducted the experiments and contributed to the analysis of data. JQ, JC, XC contributed to the analysis of data. LS and XS contributed to the analysis of data and revised the manuscript. All authors contributed to revise the manuscript and approved the final version for publication. HL, WZ and MY contributed equally to this work.
Ethics approval and consent to participate
This study was preceded in accordance with the standards of Institute Research Ethics Committee of Sun Yat-sen University Cancer Center.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 12.Bogunovic D, O'Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, et al. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival. Proc Natl Acad Sci U S A. 2009;106(48):20429–34.PubMedPubMedCentralCrossRefGoogle Scholar
- 13.Lan K, Zhao Y, Fan Y, Ma B, Yang S, Liu Q, Linghu H, Wang H. Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/beta-Catenin Signaling Pathway. Int J Mol Sci. 2017;18(5).Google Scholar
- 28.Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50.PubMedPubMedCentralCrossRefGoogle Scholar
- 30.Sun X, Zhang W, Li H, Niu C, Ou Y, Song L, Zhang Y. Stonin 2 Overexpression is Correlated with Unfavorable Prognosis and Tumor Invasion in Epithelial Ovarian Cancer. Int J Mol Sci. 2017;18(8).Google Scholar
- 32.Goodell MA: Stem cell identification and sorting using the Hoechst 33342 side population (SP). Curr Protoc Cytom 2005, Chapter 9:Unit 9 18.Google Scholar
- 35.Okamoto A, Higo M, Shiiba M, Nakashima D, Koyama T, Miyamoto I, Kasama H, Kasamatsu A, Ogawara K, Yokoe H, et al. Down-regulation of nucleolar and spindle-associated protein 1 (NUSAP1) expression suppresses tumor and cell proliferation and enhances anti-tumor effect of paclitaxel in Oral squamous cell carcinoma. PLoS One. 2015;10(11):e0142252.PubMedPubMedCentralCrossRefGoogle Scholar
- 37.Roy S, Hooiveld GJ, Seehawer M, Caruso S, Heinzmann F, Schneider AT, Frank AK, Cardenas DV, Sonntag R, Luedde M, et al. microRNA 193a-5p regulates levels of nucleolar- and spindle-associated protein 1 to suppress Hepatocarcinogenesis. Gastroenterology. 2018;155(6):1951–66 e1926.PubMedCrossRefGoogle Scholar
- 46.Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7(9):1028–34.PubMedCrossRefGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.